NC vs REGN · P/E 17, rev $237.7M vs P/E 14, rev $14.34B
NACCO Industries Inc (NC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
NACCO Industries Inc (NC) is a thermal coal company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NC revenue for 2024-12-31 was $237.7M. Net income was $33.7M. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. NC currently screens at market cap $372.1M and trailing P/E 17.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NC currently screens at market cap $372.1M and trailing P/E 17.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NC and REGN stock pages for the full models.
Not investment advice.